Bioidentical Hormones Market Estimated $300 Million by 2024: A Comprehensive Competitors Analysis By Abbott, AbbVie, ALLERGAN, Bayer, Novartis, Novo Nordisk, Orion Pharma and others

Bioidentical hormones market is accounted for USD 282.4 million in 2016 growing at a CAGR of 5.1% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Download Sample PDF Report

The report from Industry bioidentical hormones Market provides a top-to-bottom market review in terms of revenue and business sector patterns. It contains the key vendor’s company profiles and analyzes their core competencies thoroughly. The bioidentical hormones industry is fully investigating the supply, deals, creation, and market status of the report investigations. This report has the bioidentical hormones market SWOT analysis that tells you what drivers and market constraints are. The bioidentical hormones Market Supply, Deals and Market Status area, for example, also examines a number of different factors such as import, trade, net edge, value, cost, and use. Also included in this bioidentical hormones report are data including market definition, classification, applications, commitments, market drivers and market restrictions obtained through SWOT analysis.

Major Competitors:

  • Abbott
  • AbbVie
  • Bayer
  • Novartis AG
  • Novo Nordisk A/S
  • Orion Pharma AB among others.

Global Bioidentical Hormones Market Types (Estrogens, Progesterone, Testosterone, others), Product Types (Tablets & Capsules, Creams & Gels, Injectable, Patches & Implants), End Users (Hospital, Clinics, Others), Geography- Industry Trends and Forecast to 2024

Major Market Drivers and Restraints:

  • Increasing geriatric population
  • Growing screening for hormonal deficiency
  • Rising awareness


Demand Side Primary Contributors: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among other

Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Market Segmentation:

By type

  • Estrogens
  • Progesterone
  • testosterone and others.

Product types

  • tablets & capsules
  • creams & gels
  • injectable
  • patches & implants.

End user

  • hospital
  • clinics and others

On the basis of geography, global bioidentical hormones market report covers data points for 28 countries across multiple geographies such as

  • North America
  • South America
  • Europe
  • Asia-Pacific
  • Middle East
  • Africa

Some of the major countries covered in this report are

  • US., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.

Competitive Analysis:

The global bioidentical hormones market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of bioidentical hormones market for global, Europe, North America, Asia Pacific and South America.

Speak to Author @